Is short duration trastuzumab adequate adjuvant therapy for HER-2 overexpressing breast cancers?
Article
in English
| IMSEAR
| ID: sea-118144
Full text:
Available
Index:
IMSEAR (South-East Asia)
Language:
English
Year:
2006
Type:
Article
Similar
MEDLINE
...
LILACS
LIS